Clinical Trial Update: Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

A phase 1 imaging trial using 18F-FAC PET scans to assess standard treatment in people with pancreatic cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• 18F-FAC PET tracer (18F-FAC PET tracer)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING